Drug Executive Collapses During Oval Office Press Conference
During a press conference in the Oval Office, a drug executive fainted while President Donald Trump announced a deal with drugmakers to lower obesity drug prices. The event was abruptly paused due to the incident.
Details of the Incident
The executive, identified as Gordon Findlay, Novo Nordisk's global brand director, collapsed while Eli Lilly CEO David Ricks was speaking. Ricks noticed and asked,
“Are you okay? Gordon, are you okay?”
Dr. Mehmet Oz immediately assisted Findlay as he fell to his knees and lost consciousness. The press was then asked to leave the room temporarily.
Context of the Announcement
President Trump was announcing a deal involving Eli Lilly and Novo Nordisk to expand insurance coverage and reduce prices for their obesity treatments, Zepbound and Wegovy. Department of Health and Human Services Secretary was also present during the incident.
Aftermath
Approximately 30 minutes later, the press conference resumed and President Trump provided an update on Findlay's condition.
Author’s Summary
The press conference to announce a drug pricing deal was interrupted when a Novo Nordisk executive fainted, prompting immediate assistance and a brief pause before continuing.